The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.
Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...
2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...
As has been the case each year since 2022, updated COVID-19 vaccines were released leading into the fall season, and the shots should be broadly available to people age 6 months and up. For the first ...
Data in this new study shows that the 2024–2025 COVID-19 vaccines provide similar protection to the previous formulation. They were found to be most protective four weeks after vaccination, providing ...
The new study, published in JAMA Internal Medicine, found that the 2024–2025 COVID-19 vaccine continued to protect against COVID-19-associated “major adverse cardiovascular events” (MACE), which ...
It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses like Covid-19, influenza or RSV looms across the country. The US Centers for ...
As has been the case each year since 2022, updated COVID-19 vaccines were released leading into the fall season, and the shots should be broadly available to people age 6 months and up. For the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results